Skip to content
  • Home
  • Us
    • About Us
    • Values
    • Strategic Alliances
  • Technologies
    • Laboratory
  • Bioservices
    • Cryopreservation
    • Cell Expansion
  • News
    • Scientific Advances
  • Contact
    • Location
  • Virtual Tour
  • FAQs
  • Español
  • Facebook
  • Twitter
  • 7098 9133
  • contacto@indebioc.com.mx
Indebioc
  • Home
  • Us
    • About Us
    • Values
    • Strategic Alliances
  • Technologies
    • Laboratory
  • Bioservices
    • Cryopreservation
    • Cell Expansion
  • News
    • Scientific Advances
  • Contact
    • Location
  • Virtual Tour
  • FAQs
  • Español

Lung Diseases

  • Home
  • Scientific Advances
  • Lung Diseases

-Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia.

Link: https://www.ncbi.nlm.nih.gov/pubmed/28341525

Advertising License: 173300201A0623

**In the current state of stem cells research, not all transplants are successful, so the disclosed information shall avoid generating false expectations regarding the scope for the treatment of diseases through stem cells transplant from any source.**

Sanitary License: 17-TR-09-016-0003

© 2018 INDEBIOC.COM.MX ALL RIGHTS RESERVED.

  • EspañolEspañol
Copyright © All rights reserved.
  • Facebook
  • Twitter
Mediclean by WEN Themes